Cargando…

Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes

BACKGROUND: The respiratory system is exposed to various allergens via inhaled and intranasal routes. Murine models of allergic lung disease have been developed to clarify the mechanisms underlying inflammatory responses and evaluate the efficacy of novel therapeutics. However, there have been no co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Im, Song, Mi-Kyung, Lee, Kyuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902567/
https://www.ncbi.nlm.nih.gov/pubmed/31823765
http://dx.doi.org/10.1186/s12890-019-1001-9
_version_ 1783477697412857856
author Kim, Dong Im
Song, Mi-Kyung
Lee, Kyuhong
author_facet Kim, Dong Im
Song, Mi-Kyung
Lee, Kyuhong
author_sort Kim, Dong Im
collection PubMed
description BACKGROUND: The respiratory system is exposed to various allergens via inhaled and intranasal routes. Murine models of allergic lung disease have been developed to clarify the mechanisms underlying inflammatory responses and evaluate the efficacy of novel therapeutics. However, there have been no comparative studies on differences in allergic phenotypes following inhaled vs. intranasal allergen challenge. In this study, we compared the asthmatic features of mice challenged via different routes following allergen sensitization and investigated the underlying mechanisms. METHODS: To establish ovalbumin (OVA)-induced allergic asthma models, BALB/c mice were sensitized to 20 μg OVA with 1 mg aluminum hydroxide by the intraperitoneal route and then challenged by inhalation or intranasal administration with 5% OVA for 3 consecutive days. Cellular changes and immunoglobulin (Ig) E levels in bronchoalveolar lavage fluid (BALF) and serum, respectively, were assessed. Histological changes in the lungs were examined by hematoxylin and eosin (H&E) and periodic acid Schiff (PAS) staining. Levels of T helper (Th)2 cytokines including interleukin (IL)-4, -5, and -13 in BALF and epithelial cytokines including IL-25 and -33 in BALF and lung tissues were measured by enzyme-linked immunosorbent assay and western blotting. Airway hyperresponsiveness (AHR) was evaluated by assessing airway resistance (Rrs) and elastance (E) via an invasive method. RESULTS: OVA-sensitized and challenged mice showed typical asthma features such as airway inflammation, elevated IgE level, and AHR regardless of the challenge route. However, H&E staining showed that inflammation of pulmonary vessels, alveolar ducts, and alveoli were enhanced by inhaled as compared to intranasal OVA challenge. PAS staining showed that intranasal OVA challenge induced severe mucus production accompanied by inflammation in bronchial regions. In addition, Th2 cytokine levels in BALF and AHR in lung were increased to a greater extent by inhalation than by intranasal administration of OVA. Epithelial cytokine expression, especially IL-25, was increased in the lungs of mice in the inhaled OVA challenge group. CONCLUSION: OVA-sensitized mice exhibit different pathophysiological patterns of asthma including expression of epithelial cell-derived cytokines depending on the OVA challenge route. Thus, some heterogeneous phenotypes of human asthma can be replicated by varying the mode of delivery after OVA sensitization.
format Online
Article
Text
id pubmed-6902567
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69025672019-12-11 Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes Kim, Dong Im Song, Mi-Kyung Lee, Kyuhong BMC Pulm Med Research Article BACKGROUND: The respiratory system is exposed to various allergens via inhaled and intranasal routes. Murine models of allergic lung disease have been developed to clarify the mechanisms underlying inflammatory responses and evaluate the efficacy of novel therapeutics. However, there have been no comparative studies on differences in allergic phenotypes following inhaled vs. intranasal allergen challenge. In this study, we compared the asthmatic features of mice challenged via different routes following allergen sensitization and investigated the underlying mechanisms. METHODS: To establish ovalbumin (OVA)-induced allergic asthma models, BALB/c mice were sensitized to 20 μg OVA with 1 mg aluminum hydroxide by the intraperitoneal route and then challenged by inhalation or intranasal administration with 5% OVA for 3 consecutive days. Cellular changes and immunoglobulin (Ig) E levels in bronchoalveolar lavage fluid (BALF) and serum, respectively, were assessed. Histological changes in the lungs were examined by hematoxylin and eosin (H&E) and periodic acid Schiff (PAS) staining. Levels of T helper (Th)2 cytokines including interleukin (IL)-4, -5, and -13 in BALF and epithelial cytokines including IL-25 and -33 in BALF and lung tissues were measured by enzyme-linked immunosorbent assay and western blotting. Airway hyperresponsiveness (AHR) was evaluated by assessing airway resistance (Rrs) and elastance (E) via an invasive method. RESULTS: OVA-sensitized and challenged mice showed typical asthma features such as airway inflammation, elevated IgE level, and AHR regardless of the challenge route. However, H&E staining showed that inflammation of pulmonary vessels, alveolar ducts, and alveoli were enhanced by inhaled as compared to intranasal OVA challenge. PAS staining showed that intranasal OVA challenge induced severe mucus production accompanied by inflammation in bronchial regions. In addition, Th2 cytokine levels in BALF and AHR in lung were increased to a greater extent by inhalation than by intranasal administration of OVA. Epithelial cytokine expression, especially IL-25, was increased in the lungs of mice in the inhaled OVA challenge group. CONCLUSION: OVA-sensitized mice exhibit different pathophysiological patterns of asthma including expression of epithelial cell-derived cytokines depending on the OVA challenge route. Thus, some heterogeneous phenotypes of human asthma can be replicated by varying the mode of delivery after OVA sensitization. BioMed Central 2019-12-10 /pmc/articles/PMC6902567/ /pubmed/31823765 http://dx.doi.org/10.1186/s12890-019-1001-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kim, Dong Im
Song, Mi-Kyung
Lee, Kyuhong
Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes
title Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes
title_full Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes
title_fullStr Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes
title_full_unstemmed Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes
title_short Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes
title_sort comparison of asthma phenotypes in ova-induced mice challenged via inhaled and intranasal routes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902567/
https://www.ncbi.nlm.nih.gov/pubmed/31823765
http://dx.doi.org/10.1186/s12890-019-1001-9
work_keys_str_mv AT kimdongim comparisonofasthmaphenotypesinovainducedmicechallengedviainhaledandintranasalroutes
AT songmikyung comparisonofasthmaphenotypesinovainducedmicechallengedviainhaledandintranasalroutes
AT leekyuhong comparisonofasthmaphenotypesinovainducedmicechallengedviainhaledandintranasalroutes